Single nucleotide polymorphisms in lung cancer patients and cisplatin treatment

Single nucleotide polymorphisms in lung cancer patients and cisplatin treatment

Lung cancer is a major cause of mortality worldwide and non-small cell lung cancer (NSCLC) accounts for over 80% of all cases of lung cancer. Despite efforts to develop and improve early screening methods, the majority of tumors are detected at advanced stages. For over 30 years, cisplatin (CDDP), o...

Full description

Bibliographic Details
Main Authors: Agnieszka Stenzel-Bembenek, Dariusz Sagan, Małgorzata Guz, Andrzej Stepulak
Format: Article
Language:English
Published: Index Copernicus International S.A. 2014-11-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
lung cancer
cisplatin treatment
cisplatin resistance
single nucleotide polymorphism
DNA repair systems
Online Access:http://phmd.pl/gicid/01.3001.0003.1376

Internet

http://phmd.pl/gicid/01.3001.0003.1376

Similar Items